Quince Therapeutics, Inc.
USD0.92
-0.02 (-2.43%)
CEO
Dirk Thye
IPO Date
2019-05-09
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$0.93
Prev. Close
$0.94
Day Low
$0.88
Day High
$0.93
52W Low
$0.79
52W High
$45.50
Market Cap
$0.01B
Volume
0.65M
| 2,700 |
| $0.95 |
| 11 Jun 2026 | Roberts Brigette | director, officer: Chief Corp. Affairs Officer | A-Award | Acquired | 34,675 | $0.09 |
| 11 Jun 2026 | Roberts Brigette | director, officer: Chief Corp. Affairs Officer | A-Award | Acquired | 228,855 | $0.09 |
| 11 Jun 2026 | Roberts Brigette | director, officer: Chief Corp. Affairs Officer | A-Award | Acquired | 124,830 | $0.09 |
| 11 Jun 2026 | Roberts Brigette | director, officer: Chief Corp. Affairs Officer | A-Award | Acquired | 69,350 | $0.09 |
| 11 Jun 2026 | Roberts Brigette | director, officer: Chief Corp. Affairs Officer | A-Award | Acquired | 362,092 | $0.09 |
| 11 Jun 2026 | Roberts Brigette | director, officer: Chief Corp. Affairs Officer | A-Award | Acquired | 133,615 | $0.09 |
| 11 Jun 2026 | Roberts Brigette | director, officer: Chief Corp. Affairs Officer | A-Award | Acquired | 2,070,107 | $0.09 |
| 11 Jun 2026 | Roberts Brigette | director, officer: Chief Corp. Affairs Officer | A-Award | Acquired | 6,837,319 | $0.84 |